Trial Profile
Neutralizing Antibodies to Interferon beta in patients treated with Rebif New Formulation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2015
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms AIR
- 03 Aug 2011 New trial record